Genomenon

Genomenon is a private, revenue-generating company that provides a software and data platform to bridge the gap between the vast, rapidly growing body of genomic literature and actionable clinical and research insights. Its core technology, the Mastermind Genomic Intelligence Platform and the Cancer Knowledgebase (CKB), uses AI to index and curate evidence on millions of genetic variants, serving both diagnostic labs and biopharma clients. By transforming unstructured literature into structured, searchable evidence, Genomenon aims to increase diagnostic yield, de-risk drug development, and advance precision medicine.

AI-powered genomic intelligence platform (Mastermind) and Cancer Knowledgebase (CKB) that indexes and curates millions of scientific articles to provide actionable evidence on genes and variants for clinical interpretation and drug development.

Competes with other genomic interpretation software providers like Qiagen Clinical Insight, SOPHiA GENETICS, and Fabric Genomics, as well as in-house solutions at large labs. Differentiation lies in the claimed comprehensiveness of its literature index, its specialized cancer knowledgebase (CKB), and its hybrid AI-plus-expert services model.